Skip to main content
logo
Foghorn Therapeutics Inc. (FHTX)
NASDAQ: FHTX · Real-Time Price · USD
4.680
-0.080 (-1.68%)
May 4, 2026, 4:00 PM EDT - Market closed

Foghorn Therapeutics Revenue

In the year 2025, Foghorn Therapeutics had annual revenue of $30.91M with 36.75% growth. Foghorn Therapeutics had revenue of $9.25M in the quarter ending December 31, 2025, with 223.77% growth.

Revenue (ttm)
$30.91M
Revenue Growth
+36.75%
P/S Ratio
8.93
Revenue / Employee
$291,594
Employees
106
Market Cap
274.72M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202530.91M8.31M36.75%
Dec 31, 202422.60M-11.55M-33.83%
Dec 31, 202334.16M14.93M77.63%
Dec 31, 202219.23M17.91M1,357.77%
Dec 31, 20211.32M889.00K206.74%
Dec 31, 2020430.00K--
Dec 31, 2019---
Dec 31, 2018---

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Cellectis79.59M
Coherus Oncology42.17M
Editas Medicine40.52M
C4 Therapeutics35.95M
Zentalis Pharmaceuticals26.87M
LENZ Therapeutics19.09M
Artiva Biotherapeutics251.00K
Revenue Rankings

FHTX News

More News